The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Atezolizumab + obinutuzumab + venetoclax in patients with relapsed or refractory diffuse large B-cell Lymphomas (R/R DLBCL): Primary analysis of a phase II trial from LYSA.
 
Charles Herbaux
No Relationships to Disclose
 
Olivier Casasnovas
No Relationships to Disclose
 
Pierre Feugier
No Relationships to Disclose
 
Gandhi Damaj
No Relationships to Disclose
 
Reda Bouabdallah
No Relationships to Disclose
 
Stephanie Guidez
No Relationships to Disclose
 
Loic Ysebaert
Consulting or Advisory Role - Abbvie; Gilead Sciences; Janssen-Cilag; Roche; Roche
Research Funding - Gilead Sciences (Inst); Janssen-Cilag (Inst); Roche (Inst)
 
Herve Tilly
Honoraria - Bristol-Myers Squibb; SERVIER
Consulting or Advisory Role - Janssen; Karyopharm Therapeutics; Roche
Travel, Accommodations, Expenses - Roche
 
Steven Le Gouill
Honoraria - Roche/Genentech
Consulting or Advisory Role - Roche/Genentech
Research Funding - Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Luc Fornecker
No Relationships to Disclose
 
Nicolas Daguindau
No Relationships to Disclose
 
Nadine Morineau
No Relationships to Disclose
 
Corinne Haioun
No Relationships to Disclose
 
Emmanuel Gyan
No Relationships to Disclose
 
David Sibon
No Relationships to Disclose
 
Rémy Gressin
No Relationships to Disclose
 
Roch Houot
No Relationships to Disclose
 
Gilles A. Salles
Honoraria - Abbvie; Amgen; Autolus; Celgene; Gilead Sciences; Janssen; Merck; MorphoSys; Novartis; Roche/Genentech; SERVIER; Takeda
Consulting or Advisory Role - Acerta Pharma; Celgene; Epizyme; Gilead Sciences; Janssen; Kite, a Gilead company; Merck; morphosys; Novartis; Pfizer; Roche/Genentech; SERVIER
 
Franck Morschhauser
Honoraria - Abbvie; Bristol-Myers Squibb; Celgene; epizyme; Gilead Sciences; Janssen; Roche/Genentech
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Gilead Sciences; Roche/Genentech
 
Guillaume Cartron
No Relationships to Disclose